HematologyNews.net

Hematology Xagena

Search results for "Hodgkin lymphoma"

Hepatitis C virus ( HCV ) plays a role in the development of both hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma ( B-NHL ). A multicenter study, coordinated by D Vallisa, Department of ...


Four studies that highlight significant advances in treatment and survival outcomes for patients with various forms of thrombocytopenia, a group of bleeding disorders characterized by a low number of ...


Radioimmunotherapy with the radioactive drug Yttrium-90 ( 90Y ) Ibritumomab tiuxetan ( Zevalin ), following chemotherapy with Fludarabine ( Fludara ) and Mitoxantrone ( Novantrone ), is feasible, well ...


Novel treatments have shown improvements in survival and response rates for leukemia and lymphoma. The use of Dexamethasone early in the treatment of children with acute lymphoblastic leukemia, the ...


Treating relapsed follicular lymphoma patients with a milder chemotherapy regimen before they receive a blood stem cell transplant from a donor resulted in long-term complete remission for 45 of 47 pa ...


Radioimmunotherapy with the radioactive drug Yttrium-90 ( 90Y ) Ibritumomab tiuxetan ( Zevalin ), following chemotherapy with Fludarabine ( Fludara ) and Mitoxantrone ( Novantrone ), is feasible, well ...


A second generation, highly targeted monoclonal antibody appears to provide benefit for some patients with follicular lymphoma for whom other treatments have failed, according to results of a phase I ...


Four studies that highlight significant advances in treatment and survival outcomes for patients with various forms of thrombocytopenia, a group of bleeding disorders characterized by a low number of ...


A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, researchers at T ...


The incidence of a particular type of blood cancer is significantly higher in regions near facilities that release the chemical benzene into the environment. That is the conclusion of a study publishe ...


Survival data from two Brentuximab vedotin ( Adcetris ) pivotal Phase 2 clinical trials in relapsed / refractory Hodgkin lymphoma ( R/R HL ) and relapsed / refractory systemic anaplastic large cell ly ...


Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer.The study appeared in the Journal of Clinical Oncol ...


Two clinical studies published in the New England Journal of Medicine ( NEJM ) suggest that the novel agent Ibrutinib shows real potential as a safe, effective, targeted treatment for adults with chro ...


Updated interim results of a phase 2 study ( Study 102 ) evaluating GS-9973, an investigational oral inhibitor of spleen tyrosine kinase ( Syk ), for the treatment of patients with relapsed chronic ly ...


Positive results from a cohort of patients in its ongoing phase 1b trial ( CheckMate-039 ) which evaluated PD-1 immune checkpoint inhibitor, Nivolumab ( Opdivo), in patients with relapsed or refractor ...